Diagnostic potential of plasma carboxymethyllysine and carboxyethyllysine in multiple sclerosis

BACKGROUND: This study compared the level of advanced glycation end products (AGEs), N-(Carboxymethyl)lysine (CML) and N-(Carboxyethyl)lysine (CEL), in patients with multiple sclerosis (MS) and healthy controls (HCs), correlating these markers with clinical indicators of MS disease severity. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Sternberg, Zohara, Hennies, Cassandra, Sternberg, Daniel, Wang, Ping, Kinkel, Peter, Hojnacki, David, Weinstock-Guttmann, Bianca, Munschauer, Frederick
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2984414/
https://www.ncbi.nlm.nih.gov/pubmed/21034482
http://dx.doi.org/10.1186/1742-2094-7-72

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2984414/
https://www.ncbi.nlm.nih.gov/pubmed/21034482
http://dx.doi.org/10.1186/1742-2094-7-72

Ejemplares similares